Veracyte Unveils New Data at AUA 2026 on Decipher Portfolio for Urologic Cancer Care
Veracyte presents new data at the AUA 2026 conference showcasing the effectiveness of the Decipher Portfolio in enhancing personalized care for urologic cancers.
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $VCYT #AUA26–Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers